Article

Generalized anxiety disorder is under-recognized in clinical practice in patients with alcohol dependence in France.

Etablissement Public de Santé Mentale du Morbihan, rue de l'hôpital, BP 10, 56 896 St Avé Cedex, France. Electronic address: .
Alcohol (Fayetteville, N.Y.) (Impact Factor: 2.41). 10/2012; DOI: 10.1016/j.alcohol.2012.08.008
Source: PubMed

ABSTRACT Generalized Anxiety Disorder (GAD) is a frequent disabling disorder that often occurs with alcohol dependence. However comorbidity between substance use disorders and psychiatric disorders is often under-diagnosed. This study tried to evaluate an under-recognition of GAD by clinicians in alcoholic inpatients. Two groups of alcohol-dependent inpatients, hospitalized in the same non-academic psychiatric hospital in France, were included. The first group (Group 1) (n = 205) was included retrospectively within all patients hospitalized for alcohol dependence from may to November 2007. A record review was performed to determine the number of GAD (and other psychiatric disorders) diagnosis which was reported on these files by the clinicians. The second group (Group 2) (n = 199) was included prospectively from May to November 2008. GAD diagnosis was screened with the Worry and Anxiety Questionnaire and then confirmed with the Mini International Neurodiagnostic Interview. The two groups were similar in terms of social and demographic variables. GAD prevalence rate was significantly higher in Group 2 (30.7% with Confidence Interval [0.242; 0.371]) than in Group 1 (2.4% with Confidence Interval [0.003; 0.045]). This study confirms our hypothesis of an under-recognition of GAD by clinicians in alcohol dependant inpatients. It also confirms the high prevalence rate of comorbidity between alcohol dependence and GAD.

0 Bookmarks
 · 
63 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this review is, first, to cover the different aspects of visual height intolerance such as historical descriptions, definition of terms, phenomenology of the condition, neurophysiological control of gaze, stance and locomotion, and therapy, and, second, to identify warranted epidemiological and experimental studies. Vivid descriptions of fear of heights can be found in ancient texts from the Greek, Roman, and Chinese classics. The life-time prevalence of visual height intolerance is as high as 28% in the general population, and about 50% of those who are susceptible report an impact on quality of life. When exposed to heights, visual exploration by eye and head movements is restricted, and the velocity of locomotion is reduced. Therapy for fear of heights is dominated by the behavioral techniques applied during real or virtual reality exposure. Their efficacy might be facilitated by the administration of D-cycloserine or glucocorticoids. Visual height intolerance has a considerable impact on daily life and interpersonal interactions. It is much more frequent than fear of heights, which is defined as an environmental subtype of a specific phobia. There is certainly a continuum stretching from acrophobia to a less-pronounced visual height intolerance, to which the categorical distinction of a specific phobia does not apply.
    Current opinion in neurology 11/2013; 27(1). · 5.73 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Visual height intolerance occurs when a visual stimulus causes apprehension of losing balance and falling from some height. Affecting one-third of the population, it has a broad spectrum of symptoms, ranging from minor distress to fear of heights, which is defined as a specific phobia. Specific phobias are associated with higher alcohol consumption. This has not been specifically shown for susceptibility to the more general visual height intolerance. Methods Representative case-control study nested within a population-based cross-sectional telephone survey to assess epidemiologically 1253 individuals ≥14 years, using a questionnaire on sociodemographic data, typical symptoms, precipitating visual stimuli, and alcohol drinking patterns (overall frequency of alcohol consumption, the daily quantities, and the motives). Results Individuals susceptible or nonsusceptible to visual height intolerance showed no significant differences in drinking patterns. The daily average alcohol consumption was slightly higher in persons susceptible to visual height intolerance (4.1 g/day vs. 3.7 g/day). Of those consuming alcohol, cases and controls reported on average consuming 2.3 glasses per day. The prevalence of visual height intolerance was insignificantly higher in the small minority of those drinking 2-3 times per week versus teetotalers. Conclusions Our study does not provide evidence that visual height intolerance - contrary to various specific phobias - is significantly associated with individual alcohol consumption patterns.
    Brain and behavior. 09/2013; 3(5):596-601.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Erectile dysfunction in men may be due to multiple causes, including anxiety and substance abuse. The main objective of this study is to know how it affects the continued use of addictive substances in the erectile response, taking into account not only the type of substances consumed, but also other variables that may influence on sexual response, such as the time of withdrawal, anxiety and sexual attitude. Two samples were used, one for males (n = 925) who had a history of substance use and another one for males (n = 82) with no history of substance abuse. Both populations were selected by a cluster sampling of 27 Spanish provinces. The GRISS, SOS and STAI questionnaires were used. The results indicate that men with a history of consumption obtained a higher percentage of dysfunction in the erectile dysfunction questionnaire GRISS scale than those who have a history of consumption (36.69% vs.15.85%) who also have higher scores on state anxiety (19.83 vs.11.89) and trait anxiety (25.66 vs.12.39) and lowest in erotophilia (86.85 vs. 97.29) was statistically significant difference. It is also proved that the time of withdrawal does not help ex drug users improve their erectile response.
    International Journal of Clinical and Health Psychology 11/2014; · 2.79 Impact Factor